Intuitive Surgical, Inc. (ISRG) EVP Curet Myriam Sells 262 Shares
Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Curet Myriam sold 262 shares of the company’s stock in a transaction that occurred on Tuesday, January 30th. The stock was sold at an average price of $431.50, for a total transaction of $113,053.00. Following the completion of the transaction, the executive vice president now owns 2,152 shares in the company, valued at $928,588. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Intuitive Surgical, Inc. (ISRG) opened at $416.96 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $232.24 and a fifty-two week high of $452.00. The stock has a market cap of $46,719.53, a P/E ratio of 73.41, a PEG ratio of 4.91 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.27. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The company had revenue of $892.40 million during the quarter, compared to analyst estimates of $866.54 million. During the same quarter last year, the firm posted $2.03 earnings per share. The firm’s revenue was up 17.9% on a year-over-year basis. equities analysts forecast that Intuitive Surgical, Inc. will post 7.93 earnings per share for the current fiscal year.
A number of research analysts have commented on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $490.00 price target on shares of Intuitive Surgical in a research report on Friday, January 26th. Zacks Investment Research cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday, January 26th. Piper Jaffray Companies reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Friday, January 26th. Wedbush reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Finally, Evercore ISI assumed coverage on shares of Intuitive Surgical in a research report on Wednesday, January 3rd. They set an “in-line” rating and a $380.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Intuitive Surgical presently has an average rating of “Buy” and a consensus price target of $409.40.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://theolympiareport.com/2018/02/04/intuitive-surgical-inc-isrg-evp-curet-myriam-sells-262-shares.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.